Argan Inc risk profile
37 Normal where most of the sector sits
Measured 21 October 2026 from AGX's filed statements. Recomputed nightly.
37 (Normal), driven by Concentration at 88, over 7 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 75 | Stretched | Volatile | One-year price volatility — 77.5% |
| Operating pressure | 30 | Normal | Stable | Costs outgrowing revenue — -5.0 percentage points |
| Cash conversion | 2 | Contained | Easing | Capital spending against operating cash — 0.01x |
| Leverage and coverage | 15 | Contained | Stable | Current ratio — 1.59x |
| Competitive position | 22 | Normal | Stable | Operating-margin gap against peers — +4.4 percentage points |
| Concentration | 88 | Acute | Stable | Geographic concentration — 8,195 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.